Nomura Asset Management Co. Ltd. lifted its position in shares of Davita Inc (NYSE:DVA) by 2.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,004 shares of the company’s stock after purchasing an additional 567 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Davita were worth $1,286,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in DVA. Robeco Institutional Asset Management B.V. lifted its position in shares of Davita by 7.2% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 133,903 shares of the company’s stock worth $9,592,000 after purchasing an additional 8,947 shares during the last quarter. Private Advisor Group LLC purchased a new stake in Davita in the third quarter valued at $249,000. Commonwealth Equity Services LLC lifted its position in Davita by 10.2% in the third quarter. Commonwealth Equity Services LLC now owns 8,168 shares of the company’s stock valued at $585,000 after acquiring an additional 757 shares during the last quarter. ING Groep NV lifted its position in Davita by 11.7% in the third quarter. ING Groep NV now owns 15,246 shares of the company’s stock valued at $1,092,000 after acquiring an additional 1,598 shares during the last quarter. Finally, SG Americas Securities LLC lifted its position in Davita by 313.5% in the third quarter. SG Americas Securities LLC now owns 25,199 shares of the company’s stock valued at $1,805,000 after acquiring an additional 19,105 shares during the last quarter. 85.66% of the stock is owned by institutional investors and hedge funds.
Shares of DVA opened at $53.53 on Friday. Davita Inc has a 1-year low of $48.25 and a 1-year high of $79.11. The firm has a market capitalization of $8.91 billion, a P/E ratio of 14.99, a P/E/G ratio of 0.51 and a beta of 1.30. The company has a debt-to-equity ratio of 2.09, a current ratio of 1.72 and a quick ratio of 1.70.
A number of equities research analysts recently weighed in on the stock. Raymond James cut shares of Davita from an “outperform” rating to a “market perform” rating and set a $63.44 price target for the company. in a research report on Sunday, December 2nd. UBS Group raised shares of Davita from a “sell” rating to a “neutral” rating and reduced their price target for the company from $64.00 to $59.00 in a research report on Tuesday, January 8th. Zacks Investment Research raised shares of Davita from a “sell” rating to a “hold” rating in a research report on Thursday, February 14th. ValuEngine cut shares of Davita from a “hold” rating to a “sell” rating in a research report on Wednesday, January 2nd. Finally, Robert W. Baird reduced their price target on shares of Davita from $90.00 to $70.00 and set an “outperform” rating for the company in a research report on Friday, February 15th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $66.92.
TRADEMARK VIOLATION NOTICE: “Davita Inc (DVA) Stake Raised by Nomura Asset Management Co. Ltd.” was originally reported by PressOracle and is owned by of PressOracle. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://pressoracle.com/news/2019/03/17/davita-inc-dva-stake-raised-by-nomura-asset-management-co-ltd.html.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Article: How to Use the New Google Finance Tool
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.